These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
6. [Estrogen substitution and endometrial carcinoma]. Kruyver GP Ned Tijdschr Geneeskd; 1979 Mar; 123(10):383-7. PubMed ID: 216933 [TBL] [Abstract][Full Text] [Related]
7. [Should the menopause be treated ? When and how? (author's transl)]. Soria R Sem Hop; 1980 Sep 18-25; 56(33-36):1374-9. PubMed ID: 6252629 [TBL] [Abstract][Full Text] [Related]
8. [Cancer risk of hormone replacement treatment in the menopause]. Pejovic-Lenfant MH J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):153-66. PubMed ID: 2656835 [TBL] [Abstract][Full Text] [Related]
10. [Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)]. Lachnit-Fixson U Wien Klin Wochenschr; 1979 Feb; 91(4):111-8. PubMed ID: 218369 [TBL] [Abstract][Full Text] [Related]
11. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. Thomas DB; Persing JP; Hutchinson WB J Natl Cancer Inst; 1982 Nov; 69(5):1017-25. PubMed ID: 6957648 [TBL] [Abstract][Full Text] [Related]
12. [Menopause, estrogens and genital cancer]. Kuttenin F Soins; 1978 Apr; 23(7):23-6. PubMed ID: 249020 [TBL] [Abstract][Full Text] [Related]
13. Progestogen deficiency and endometrial cancer risk. Schindler AE Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117 [TBL] [Abstract][Full Text] [Related]
14. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia. Brzezinski A; Schenker JG Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033 [TBL] [Abstract][Full Text] [Related]
15. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
16. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Zanetta GM; Webb MJ; Li H; Keeney GL Gynecol Oncol; 2000 Oct; 79(1):18-22. PubMed ID: 11006024 [TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880 [TBL] [Abstract][Full Text] [Related]
18. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763 [TBL] [Abstract][Full Text] [Related]
19. Risk factors in endometrial carcinoma with special reference to the use of estrogens. Salmi T Acta Obstet Gynecol Scand Suppl; 1979; 86():1-119. PubMed ID: 377899 [No Abstract] [Full Text] [Related]